Cargando…
P656: NOVEL THIAZOLIDINEDIONE WITH HDAC INHIBITING PROPERTIES OPTIMIZED FOR CHRONIC MYELOID LEUKEMIA TREATMENT
Autores principales: | Rams, Anna, Laskowska, Paulina, Cieloch, Adrianna, Tilekar, Kalpana, Upadhyay, Neha, Ramaa, C.S., Mrowka, Piotr, Głodkowska-Mrówka, Eliza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429157/ http://dx.doi.org/10.1097/01.HS9.0000969528.49452.60 |
Ejemplares similares
-
P393: GENETIC CHARACTERISTICS OF PEDIATRIC B-OTHER ACUTE LYMPHOBLASTIC LEUKEMIA COHORT USING TARGETED RNA SEQUENCING
por: Głodkowska-Mrówka, Eliza, et al.
Publicado: (2023) -
PB1710: AN EXTENDED FLOW CYTOMETRY PANEL AS A SCREENING TOOL FOR PH-LIKE ALL
por: Cieloch, Adrianna, et al.
Publicado: (2023) -
Hypoglycemic and Hypolipidemic Swords: Synthesis and In-vivo Biological Assessment of 5-benzylidene-2,4-thiazolidinediones
por: Patil, Vijay, et al.
Publicado: (2021) -
Mechanistic Insights into Binding of Ligands with Thiazolidinedione Warhead to Human Histone Deacetylase 4
por: Schweipert, Markus, et al.
Publicado: (2021) -
Dynamic Changes in the Ability to Release Neutrophil ExtraCellular Traps in the Course of Childhood Acute Leukemias
por: Ostafin, Magdalena, et al.
Publicado: (2021)